Roche announces positive data from global phase III programme for crovalimab in PNH, a rare life-threatening blood condition February 7, 2023February 7, 2023 by / Share This.....LinkedinTwitterFacebookGoogleEmailRelated News: [Ad hoc announcement pursuant to Art. 53 LR] Roche…Roche announces positive Phase III results for…Roche announces positive data from broad blood…Roche’s subcutaneous formulation of Tecentriq…Positive topline phase III results show Roche's…FDA grants priority review to Xolair (omalizumab)…
